BlackRock Science and Technology Trust II (BSTZ) Financials
$31.05
As on 11-Sep-2026 13:34EDT
Market cap
$2,089 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
6.6
P/B Ratio
1.2
Div. Yield
0 %
Income Statement ($ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
265.96
|
274.17
|
-34.32
|
-1,334.22
|
250.71
|
1,486.87
|
|||||
|
Cost of Revenue
|
20.58
|
0.00
|
20.44
|
25.92
|
41.18
|
26.01
|
|||||
|
Gross Profit
|
245.38
|
274.17
|
-54.76
|
-1,334.22
|
250.71
|
1,486.87
|
|||||
|
Operating Expenses
|
-69.41
|
1.90
|
2.24
|
1.84
|
2.16
|
1.87
|
|||||
|
Operating Profit (EBIT)
|
314.79
|
272.28
|
279.96
|
-1,336.06
|
248.55
|
1,485.00
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
314.36
|
272.28
|
279.96
|
-1,336.06
|
248.55
|
1,485.00
|
|||||
|
Provision for Tax
|
--
|
--
|
-0.17
|
-0.49
|
-0.84
|
-0.55
|
|||||
|
Profit after Tax (Net Income)
|
314.36
|
272.28
|
290.15
|
-1,336.06
|
248.55
|
1,485.00
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
--
|
--
|
--
|
--
|
--
|
--
|
Liabilities ($ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,717.10
|
1,374.88
|
1,196.42
|
960.70
|
1,681.17
|
1,297.34
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
18.50
|
13.42
|
26.89
|
16.53
|
26.07
|
24.45
|
|||||
|
Current Liabilities
|
17.50
|
2.48
|
3.21
|
1.22
|
12.34
|
1.76
|
|||||
|
Total Liabilities
|
1,753.11
|
1,698.70
|
1,657.70
|
968.54
|
1,707.24
|
1,321.80
|
Assets ($ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1,721.20
|
1,688.79
|
1,645.53
|
965.25
|
3,031.48
|
1,318.73
|
|||||
|
Current Assets
|
31.91
|
9.91
|
12.17
|
8.00
|
49.27
|
0.41
|
|||||
|
Total Assets
|
1,753.11
|
1,698.70
|
1,221.30
|
968.54
|
1,707.24
|
1,321.80
|
|||||
|
Total Debt*
|
17.50
|
7.49
|
3.21
|
0.09
|
--
|
--
|
|||||
|
Net Current Assets
|
--
|
--
|
--
|
--
|
--
|
--
|
Cashflow ($ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-47.75
|
94.11
|
-42.77
|
183.81
|
213.93
|
107.17
|
|||||
|
Cash Flow from Investing Activities
|
324.34
|
323.54
|
86.39
|
88.70
|
342.25
|
240.44
|
|||||
|
Cash from Financing Activities
|
-256.13
|
-94.46
|
-175.85
|
-183.98
|
-225.09
|
-96.98
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
4.57
|
7.84
|
8.45
|
-40.49
|
3.18
|
19.02
|
|||||
|
Cash EPS ($)
|
4.57
|
7.84
|
8.45
|
-40.49
|
3.18
|
19.02
|
|||||
|
Adjusted Book Value ($)
|
24.98
|
39.60
|
34.84
|
29.11
|
21.52
|
16.61
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
-0.69
|
2.71
|
-1.25
|
5.57
|
2.74
|
1.37
|
|||||
|
Free Cash Flow per Share ($)
|
-0.69
|
2.71
|
-1.00
|
5.57
|
2.74
|
1.37
|
Profitability Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
20.17
|
21.09
|
26.86
|
-101.14
|
16.69
|
140.96
|
|||||
|
ROE (%)
|
20.33
|
21.18
|
26.90
|
-101.14
|
16.69
|
145.59
|
|||||
|
ROA (%)
|
18.21
|
16.22
|
22.10
|
-99.86
|
16.41
|
143.06
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
-845.52
|
100.14
|
99.14
|
99.87
|
|||||
|
Net Margin (%)
|
118.20
|
99.31
|
-845.44
|
100.14
|
99.14
|
99.87
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.03
|
8.99
|
0.97
|
-6.32
|
-0.83
|
12.07
|
|||||
|
EBIT Growth (%)
|
--
|
--
|
121.72
|
-637.54
|
-83.26
|
1,211.50
|
|||||
|
Net Profit Growth (%)
|
15.45
|
-6.16
|
121.72
|
-637.54
|
-83.26
|
1,211.50
|
|||||
|
EPS Growth (%)
|
-0.42
|
-0.07
|
1.21
|
-13.72
|
-0.83
|
13.47
|
|||||
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
4.94
|
2.64
|
1.98
|
-0.39
|
12.24
|
1.91
|
|||||
|
Price / Book Value
|
0.91
|
0.52
|
0.48
|
0.54
|
1.81
|
2.19
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
4.90
|
2.63
|
1.97
|
-0.38
|
12.06
|
1.91
|
|||||
|
Close Price ($)
|
22.61
|
20.71
|
16.71
|
15.64
|
38.94
|
36.38
|
|||||
|
High Price ($)
|
23.30
|
22.28
|
19.28
|
39.13
|
43.76
|
38.35
|
|||||
|
Low Price ($)
|
15.22
|
16.21
|
14.11
|
15.30
|
32.07
|
12.00
|
|||||
|
Market Cap ($ Cr)
|
--
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.01
|
0.01
|
0.00
|
0.00
|
--
|
--
|
|||||
|
Short term debt to equity ratio
|
0.01
|
0.01
|
0.00
|
--
|
--
|
--
|
|||||
|
Current Ratio
|
1.82
|
4.00
|
3.79
|
6.57
|
3.99
|
0.23
|
|||||
|
Quick Ratio
|
--
|
--
|
--
|
-19.26
|
--
|
-12.13
|
|||||
|
Interest Coverage
|
--
|
--
|
19,934.94
|
--
|
--
|
--
|
Operating Efficiency Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.59
|
0.06
|
-6.08
|
-0.22
|
4.12
|
0.14
|
|||||
|
Asset Turnover
|
0.15
|
0.16
|
-0.03
|
-1.00
|
0.17
|
1.43
|
|||||
|
Receivable days
|
1.18
|
1.49
|
-27.01
|
-1.82
|
9.05
|
0.56
|
|||||
|
Inventory Days
|
--
|
--
|
561.66
|
568.67
|
314.96
|
1,302.13
|
|||||
|
Payable days
|
249.67
|
162,829.20
|
24.03
|
94.93
|
62.54
|
23.03
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
510.62
|
471.92
|
261.46
|
1,279.67
|